Woodcock, M., Anders, C., Swearingen, A. V., Moore, D., Sambade, M., Cuaboy, L., Garrett, A., McKinnon, K., Cowens, K., Bortone, D., Calhoun, B., Carey, L., Dees, C., Jolly, T., Muss, H., Reeder-Hayes, K., Kaltman, R., Jankowitz, R., Gudena, V., Olajide, O., Perou, C., Vincent, B., & Serody, J. (n.d.). 258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal for immunotherapy of cancer, 8, A281–A282. http://access.bl.uk/ark:/81055/vdc_100144730307.0x000005